White spot syndrome virus (WSSV) is a large enveloped virus which has caused severe mortality and huge economic losses in the shrimp farming industry. The enveloped virus must be combined with the receptors of the host cell membrane by the virus envelope proteins. In the case of WSSV, binding of envelope proteins with receptors of the host cell membrane was discovered in a number of previous studies, such as VP53A and 10 other proteins with chitin-binding protein (CBP), VP28 with Penaeus monodon Rab7, VP187 with b-integrin, and so on. WSSV envelope proteins were also considered capable of forming a protein complex dubbed an 'infectome'. In this study, the research was focused on the role of CBP in the WSSV infection process, and the relationship between CBP and the envelope proteins VP24, VP28, VP31, VP32 VP39B, VP53A and VP56. The results of the reverse transcription-PCR analyses showed that CBP existed in a variety of shrimp. The speed of WSSV infection could be slowed down by inhibiting CBP gene expression. Far-Western blot analysis and His pull-down assays were conducted, and a protein complex was found that appeared to be composed of a 'linker' protein consisting of VP31, VP32 and VP39B together with four envelope proteins, including VP24, VP28, VP53A and VP56. This protein complex was possibly another part of the infectome and the possible binding region with CBP. The findings of this study may have identified certain points for further WSSV research.
INTRODUCTION
White spot syndrome virus (WSSV) is one of the most serious pathogens that cause viral infections in the shrimp culture industry throughout the world. This virus has a broad host range consisting of most of the crustaceans. WSSV (genus Whispovirus, family Nimaviridae) is a large, enveloped, ellipsoid and dsDNA virus (Wang et al., 1995; Wongteerasupaya et al., 1995; Lo et al., 1996; Leu et al., 2009; Escobedo-Bonilla et al., 2008) . Although considerable progress has been made in determining WSSV genomics and structural proteins, the early stage of the morphogenesis of the viral infection process into the host cell has only starting to be discovered recently.
At present, at least WSSV 58 structural proteins have been identified. In addition, .30 proteins have been classified as envelope proteins within the structural proteins (Tsai et al., 2004 (Tsai et al., , 2006 Zhang et al., 2004 ). As we know, an enveloped virus must utilize the viral envelope proteins to connect itself to the host cell before infection.
There have been some studies focusing on the interaction between WSSV envelope proteins and their counterparts on host cells such as VP28/Penaeus monodon Rab7 (PmRab7), VP53A/Penaeus monodon chitin-binding protein (PmCBP, renamed as CBP in this study) and VP187/b-integrin, and the experiments showed that blocking the interaction between WSSV envelope proteins and their counterparts can delay WSSV infection (Sritunyalucksana et al., 2006; Chen et al., 2007b; Li et al., 2007) . Recently, the interaction between eight WSSV envelope proteins (WSV010, VP19, VP24, VP26, VP28, VP37, VP38A and VP51C) was further confirmed (Chang et al., 2008 (Chang et al., , 2010 Chen et al., 2007a Chen et al., , 2009 Jie et al., 2008; Liu et al., 2009; Wan et al., 2008; Zhou et al., 2009) . With more protein interactions being discovered, research attention has shifted from the interaction between pairs of proteins to the interaction between multiprotein complexes (Zhou et al., 2009; Chang et al., 2010; Chen et al., 2009) . The 'infectome' concept was proposed after the interaction between nine structural proteins was identified (Chang et al., 2010) .
In our previous research, the yeast-two hybrid (Y2H) system revealed that CBP can interact with 11 WSSV envelope proteins, and it can reduce and delay mortality IP: 54.70.40.11
On: Thu, 27 Jun 2019 07:33:24 upon WSSV challenge (Chen et al., 2009 ). Thus, this study investigated the interaction of those viral envelope proteins with CBP and the process of formation of the relevant protein complex (the 'infectome'). VP28, the well-investigated envelope protein of WSSV, and six other envelope proteins, VP24, VP31, VP32, VP39B, VP53A and VP56, were selected to have their interactions analysed. VP28 is not only the most abundant envelope protein in the viral envelope membrane, but also part of the infectome that can interact with VP24, VP26 and VP37 (Liu et al., 2009; Chang et al., 2010) . VP24, the product of the wsv002 gene of WSSV, is also a major envelope protein of WSSV. VP24 is considered the core of the infectome because it can interact with WSV010, VP19, VP26, VP28, VP33, VP38A and VP51A (Chang et al., 2010) . VP31 contains a conserved Arg-Gly-Asp (RGD) motif, which is speculated to show cell adhesion activity (Li et al., 2011) . VP53A can interact with CBP (Chen et al., 2007b) . Moreover, injecting any one of the four recombinant proteins, VP24, VP28, VP31 and VP53A, was shown to reduce WSSV infection efficiency by immunoneutralization (Chen et al., 2009; Xie & Fang, 2006b; Li et al., 2005; Witteveldt et al., 2004) . However, information about the other three envelope proteins, VP32, VP39B and VP56, is lacking. Thus, in this study we investigated the interaction of seven viral envelope proteins and identified a new protein complex (infectome) that mediated WSSV infection via CBP.
RESULTS

Importance of CBP in the WSSV infection pathway
To determine whether the CBP gene was expressed in other WSSV host species, Penaeus vannamei (also known as Litopenaeus vannamei) and six other species (Macrobrachium rosenbergii, Atyopsis spinipes, Procambarus clarkii, Marsupenaeus japonicus, Neocaridina denticulata and Macrobrachium nipponense) were selected for analysis. The CBP gene or CBPhomologous gene was detectable in N. denticulata, Penaeus vannamei, Macrobrachium rosenbergii, A. spinipes, Procambarus clarkii, Macrobrachium nipponense and Marsupenaeus japonicus by reverse transcription (RT)-PCR (Fig. 1a) , indicating that the gene might exist in other WSSV host species. As CBP is apparently not specific to Penaeus monodon, the simplified term 'chitin-binding protein (CBP)' will be used instead of PmCBP to avoid confusion with regard to species.
Furthermore, in order to understand the role of CBP during WSSV infection, RNA inference (RNAi) was applied to investigate whether WSSV infection would be affected. The dsRNA specific to the CBP gene was injected into Penaeus vannamei and CBP expression was determined. CBP was almost knocked-down 2 days after injection (Fig. 2a) . In this study, WSSV was injected into experimental shrimp 3 days after dsRNA injection and virus infection could clearly be delayed (Fig. 2c) , implying that CBP did actually play an important role in WSSV infection.
CBP interacted with multiple WSSV envelope proteins
In our previous study, the interaction between CBP with the 11 WSSV envelope proteins was identified by Y2H analysis (Chen et al., 2009) . As several proteins failed to be produced in prokaryotic or eukaryotic protein production systems, only seven proteins were selected to verify the interaction by far-Western blot analysis in this study. The recombination envelope protein data are shown in Fig. 3 .
In the far-Western blot analysis, after hybridization with CBP and reaction with anti-CBP antiserum, the results indicated that CBP could interact with VP24, VP31, VP32, VP39B and VP56 (Fig. 4b) . The interactions between CBP/ VP53A and CBP/VP28 were set as positive and negative controls, respectively, because the interactions between them had been analysed previously (Chen et al., 2009 ). An obvious band was detected at the location of 48 kDa, which is double the molecular mass of VP24. It indicated that VP24 might form a dimer structure on the envelope of WSSV. Furthermore, it also demonstrated that VP31 might form a dimer (indicated at~62 kDa). The recombination VP32 and VP39B showed multiple bands. This was probably due to the degradation of recombination proteins. These results confirmed that multiple WSSV envelope proteins can make up a protein complex to interact with CBP during infection.
Interactive relationship between VP24, VP28, VP31, VP32, VP39B, VP53A and VP56
As CBP can interact with multiple WSSV envelope proteins, it has become particularly important to understand the precise interaction between these envelope proteins and the formation of this protein complex. In this study, farWestern blotting was selected to identify the proteinprotein interaction. Due to the fact that several proteins failed to be produced in prokaryotic or eukaryotic protein production systems, only seven envelope proteins (rVP24, rVP28, rVP31, rVP32, rVP39B, rVP53A and rVP56) were selected to verify the interaction.
The far-Western blot assay results showed that VP24 interacted with VP28, VP31, VP32 and VP39B, but did not interact with VP53A and VP56 (Fig. 5a ). VP28 is the most abundant envelope protein in the WSSV envelope membrane . However, the result showed that the binding reaction only happened between VP28 and VP24 (Fig. 5b) . VP31 can associate with VP24, VP32 and VP39B, but not interact with VP28, VP53A and VP56 (Fig. 5c ). VP32 can interact with VP24, VP31, VP39B and VP53A, but not interact with VP28 and VP56 (Fig. 5d ). VP39B can interact with VP24, VP31, VP32, VP53A and VP56, but not interact with VP28 (Fig. 5e ). VP53A can associate with VP24, VP31, VP32 and VP39B, but interacted with neither VP28 nor VP56 (Fig. 5f ). Due to protein interaction relationships analysed previously, here CBP/VP53A, CBP/VP31, CBP/ VP32, CBP/VP39B and VP24/VP28 were set as positive controls, and CBP/VP28 was set as a negative control.
Confirmation of the interaction between viral envelope proteins by His pull-down assay
To confirm the results of the far-Western blot assay, a modified His pull-down assay was used. Each His-recombinant envelope protein (rVP24, rVP28, rVP31, rVP32, rVP39B and rVP53A) was immobilized on nickel nitrilotriacetic acid (Ni-NTA) beads, incubated with purified WSSV virion and then the protein interaction was identified by Western blotting (Fig. 6 ). The result indicated that rVP24 could bind with VP28, VP31, VP32, VP39B and VP53A (Fig. 6a, g ). rVP28 only interacted with VP24 ( Fig. 6b, g ). The data confirmed the result shown in far-Western blotting (Fig. 5a , b). VP24, VP32, VP39B and VP53A were contained in the rVP31 elution (Fig. 6c, h ). VP24, VP31, VP39B and VP53A were contained in the rVP32 elution (Fig. 6d, g, h) . VP24, VP31, VP32 and VP53A were contained in the rVP39B elution (Fig. 6e, g, h) . VP24, VP31, VP32 and VP39B were contained in the rVP53A CBP (Fig. 6f , g, h). The interaction between maltose-binding protein (MBP) and viral proteins was set as the negative control in this study. The result of the His pull-down assay is consistent with the result of farWestern blotting.
Proposed schematic model of the infectome complex on the WSSV envelope
Combining the results shown in Figs 4-6, more detailed information of this relationship can be gained from Table  1 . What is their conformation and interaction in vivo?
The understanding of the topology predictions for VP24, VP28, VP31, VP32, VP39B, VP53A and VP56 can help to theorize a schematic model. According to the prediction results of the TMHMM program; VP24, VP28 and VP56 have a transmembrane helix of 23 aa at their N terminus. VP31, VP32 and VP39B all have similar prediction results. None of these proteins has a putative transmembrane domain. The C terminus of VP53A was predicted to be exposed outside of the virion envelope, and contains three transmembrane helices at aa 956-978, 1144-1166 and 1181-1203. According to the putative interactions within these seven envelope proteins (Table 1 ) and the infectome concept (Chang et al., 2010) , a matrix diagram showing the relationships in this study was theorized and is shown in Fig. 7 (a). The threedimensional (3D) structure model created using Google SketchUp 8.0 is shown to help understand the formation and interaction in vivo (Fig. 7a, b ).
DISCUSSION
When enveloped viruses invade host cells, they typically attach themselves to the surface of the host cell. In order to enter the host cell, enveloped virus may connect with single or multiple receptors by their envelope proteins. For example, CD21 on the surface of human cells is the only receptor for Epstein-Barr virus. In contrast, gp120, the envelope protein of human immunodeficiency virus, binds itself to CD4 first and then associates with its co-receptors, the chemokine receptors CXCR4 and CCR5 (Huang et al., 1995; Feng et al., 1996) . Several studies have noted that WSSV envelope proteins bind to the host cell receptors, such as VP28 with PmRab7, VP53A with PmCBP and VP187 with b-integrin. Recombinant WSSV envelope proteins or antibody can be applied to block the binding relationship between these virus proteins and the host cell receptors, which is usually able to delay WSSV infection, but cannot effectively prevent WSSV from entering host cells, which suggests there is a different mechanism at work. The more likely explanation for this is that WSSV might have multiple envelope proteins that bind to multiple receptors. A framework for the WSSV protein complex -the infectome -proposed by Chang et al. (2010) also supports this speculation.
CBP has been shown to interact with VP53A together with other envelope proteins (Chen et al., 2009) . RT-PCR analysis revealed that CBP-homologous gene expression can also be found in other WSSV host species (Fig. 1) . Many of them are important aquaculture species, such as the white-leg shrimp Penaeus vannamei, the kuruma shrimp Marsupenaeus japonicus and the Japanese prawn Macrobrachium nipponense. The analysis indicated that the CBP gene exists 15 M a r k e r r V P 2 4 r V P 3 1 r V P 3 2 r V P 3 9 B r V P 5 6 r V P 5 3 A r V P 2 8 r C B P r V P 2 4 r V P 3 1 r V P 3 2 r V P 3 9 B r V P 5 6 r V P 5 3 A r V P 2 8 r C B P Fig. 4 . CBP interacts with rVP24, rVP31, rVP32, rVP39B, rVP53A and rVP56. (a) Coomassie brilliant blue-stained 12 % SDS-PAGE gel. (b) Far-Western blotting was used to determine the interaction between CBP and WSSV envelope proteins with anti-CBP antibody. rVP24, rVP31, rVP32, rVP39B, rVP56 and rVP53A can interact with rCBP, but rVP28 cannot interact with rCBP. rVP53A was used as a positive control and rVP28 was used as a negative control. Each well was loaded with 20 mg protein.
extensively in a wide variety of shrimp. However, knockingdown CBP gene expression only reduced, but did not totally prevent, WSSV infection in shrimp. This may be due to the dsRNA specific to CBP, which did, in this particular case, not knock-down the entire CBP gene in the living organism. Once a few cells continue to express CBP, the virus could have the chance to infect the cell and start its morphogenesis. Nevertheless, the results still support the idea that CBP plays an important role during WSSV infection (Fig. 1 ).
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the core of this protein complex even though it is the most abundant envelope protein and can bind with PmRab7. VP28 might be the peripheral component around the complex or infectome. This may suggest that VP53A and other proteins may compose a previously unknown protein complex or be part of an (possibly another) infectome (Table 1) .
According to the results from some protein structure prediction methods, such as SOSUI and TMHMM, VP31, VP32 and VP39B are envelope proteins without any transmembrane domain (TMD) and these envelope proteins could anchor on the cell membrane by interacting with other viral envelope proteins with TMDs. Thus, VP31, VP32 together with VP39B might form a 'linker' in the Ab: anti-VP28 
rVP53A MBP Fig. 6 . His pull-down assay confirms the interaction relationships between seven WSSV envelope proteins. (a-h) His pull-down assays of His-tagged WSSV envelope proteins (rVP24, rVP28, rVP31, rVP32, rVP39B and rVP53A) with purified WSSV. After separation by SDS-PAGE, input protein(s) were confirmed by specific antisera. The interaction between rMBP and viral protein was used as a negative control. +, Expressed proteins with an interaction; -, expressed proteins without an interaction; Ab, antibody.
complex to connect the other four envelope proteins VP24, VP28, VP53A and VP56. Although the interaction with VP31/VP53A and VP24/VP53A can be identified from the far-Western blotting experiment, the same experiments for VP31 and VP24 have contrarily shown no interaction with VP53A. These results may be explained by considering that the binding region is blocked when rVP53A is transferred to PVDF. However, the His pull-down assay can confirm this interaction. VP24 can interact with VP53A and VP28, whilst VP53A does not connect with VP28. One explanation for this is that VP24 might be the linker between VP53A and VP28. Additional research on the interactions between VP24 and VP56 will be needed. VP39B could interact with the all other proteins except VP28. This indicated that VP39B not only linked with VP31 and VP32, but also with VP56 and VP53A. The C-terminal region of VP53A was predicted to be embedded in the viral envelope membrane and a large part of the N-terminal region was predicted to be located outside of the membrane. The farWestern blotting and His pull-down assay results showed that VP53A can interact with VP24, VP31, VP32 and VP39B, but cannot interact with VP28 and VP56. In farWestern blotting, some recombinant proteins often have extra bands, but this phenomenon was rare in the His pulldown assay. This may have contributed to the degradation of recombinant proteins during far-Western blotting.
Thus, a logically plausible 3D model was proposed in this study after identifying the interaction between seven viral envelope proteins (Fig. 7) . In this model, three envelope proteins VP28, VP53A and VP56 with TMDs do not interact with each other. Compared with VP28 and VP56, VP53A interacts with more proteins so that it should act as a core in this complex. In addition, VP53A interacts with VP28 and VP56 via VP24 and the VP31-VP32-VP39B linker, respectively. In previous infectome studies, VP24 was known as a core protein because it could interact with several proteins, including VP28 identified previously by far-Western blotting and co-immunoprecipitation assays . The location of the C terminus of VP24 is unclear. In previous studies, the recombinant VP24 expressed without the N-terminal TMD could interact with VP28 (Xie & Fang, 2006b) , which means that VP24 and VP28 should be located at the same side in the virion envelope membrane, and VP24 can bind with CBP. We consider that the C terminus of VP24 probably locates at the exterior of viral envelope and associates with other viral proteins to form a protein complex.
In conclusion, these envelope proteins could form a large infectome complex and can be divided into two groups according to their binding ability with the host cell's speculated receptor, CBP. One group is composed of six proteins (VP19, VP26, VP28, VP38A, VP51A and VP51C) that may not bind with CBP. The other group is composed of six proteins (VP28, VP31, VP32, VP39B, VP53A and VP56) with VP53A as the core that can bind with CBP. These two groups are linked by VP24. VP56 connects to the complex via the VP31-VP32-VP39B linker. However, more studies are needed on the interaction between those two protein complexes. Although the protein-protein interaction results might not truthfully represent the in vivo situation of viral infectome binding with CBP, they still indicate that the CBP-binding region plays an important role in virus attachment.
METHODS
Virus purification. WSSV Taiwan-1 strain was collected in 1994 in Taiwan from infected Penaeus monodon (Wang et al., 1995) . The haemolymph was collected from experimentally WSSV-infected shrimp (Penaeus vannamei; mean weight 15 g), diluted 1 : 4 with PBS and frozen at 280 uC. From this virus stock, a sample (0.5 ml) was centrifuged (1500 g for 10 min), and the supernatant was filtered (0.45 mm filter) and injected (0.1 ml; 1 : 100 dilution in PBS) intramuscularly into five healthy 20 g crayfish (Procambarus clarkii) between the second and third abdominal segments. Between 5 and 7 days after injection, the crayfish, which were verified to be infected with WSSV, were collected for WSSV preparation. All tissues, excluding the hepatopancreas, were homogenized for 2 min using a mechanical homogenizer (IKA T-25) in 200 ml TNE buffer (50 mM Tris/HCl, 500 mM NaCl, 5 mM EDTA, pH 8.5) containing protease inhibitors (1 mM PMSF) on ice and then centrifuged at 6000 g for 5 min. The supernatant was filtered through a nylon net (400 mesh) Binding protein Target protein   CBP  VP24  VP28  VP31  VP32  VP39B  VP53A  VP56 CBP
Expressed proteins with an interaction; -, expressed proteins without an interaction. *Far-Western interaction result is not consistent.
and centrifuged at 30 000 g for 30 min. After the supernatant was discarded, the upper loose layer (pink) of the pellet was rinsed out carefully using a dropper and the lower compact grey layer was resuspended in 2 ml TESP buffer (50 mM Tris/HCl, 5 mM EDTA, 500 mM NaCl, pH 8.5). The crude virus suspensions were centrifuged at 6000 g for 5 min and the supernatant was centrifuged again at 30 000 g for 30 min. After the supernatant and pink loose layer were removed, the white pellet was resuspended in 0.2 ml TM buffer (50 mM Tris/HCl, 5 mM MgCl 2 , pH 7.5) and transferred to two 1.5 ml tubes. The suspension was centrifuged three times at 800 g for 3 min each time to remove pink impurities . Finally, the white pure virus suspension was stored at 4 uC until use. The purity of the virus preparation was evaluated by negative-staining transmission electron microscopy (Zhou et al., 2007) .
RNA isolation and RT-PCR. Total RNA isolation from the pleopods of N. denticulata, Penaeus vannamei, Macrobrachium rosenbergii, A. spinipes, Procambarus clarkii, Macrobrachium nipponense and Marsupenaeus japonicus was as described previously (Chen et al., 2007b) with the following modification. Briefly, tissues (100 mg) were homogenized in 1 ml TRIzol reagent (Invitrogen), and then subjected to 2-propanol extraction and ethanol precipitation according to the manufacturer's recommendations. Total RNA was centrifuged in 75 % ethanol at 14 000 g for 30 min at room temperature. The pellet was dissolved in DEPC-water and quantified by spectrophotometry.
After RNA extraction, an aliquot of 1 mg RNA was treated with 1 ml RNase-free DNase I (Roche) at room temperature for 30 min to remove any viral genomic DNA contamination and then re-extracted with phenol/chloroform. The DNase-treated total RNA was denatured by heating at 65 uC for 5 min in 11 ml DEPC-water containing 50 mM oligo(dT)-anchor primer (Roche) and 1 ml 10 mM dNTP mix. The first-strand cDNA was synthesized by the addition of 4 ml 56 First-Strand buffer, 2 ml 0.1 M DTT, 1 ml RNase inhibitor and 1 ml HiScript I Reverse Transcriptase (Bionovas). The reaction proceeded at 42 uC for 1 h and was terminated at 72 uC for 15 min. Then, the cDNA was treated with 2 ml RNase H to remove the RNA template from the cDNA. Further, the appropriate genespecific primers, T7-LvCBP-dsRNA-F/T7-LvCBP-dsRNA-R for CBP and actin-F/actin-R (Table S1 , available in the online Supplementary Material) for shrimp b-actin, were then used for PCR.
In vivo gene silencing by dsRNA injection. Preparation of dsRNA was as described by Wang et al. (2010) . Briefly, DNA templates corresponding to CBP and EGFP sequences for dsRNA synthesis were amplified by PCR using gene-specific primers (T7-LvCBP-dsRNA-F/ T7-LvCBP-dsRNA-R; see above), which were incorporated to the T7 RNA polymerase binding site at the 59 terminus to produce sense and antisense strands separately. After DNA templates were purified, the ssRNAs were generated in vitro using T7 RiboMAX Express (Promega). Each corresponding ssRNA was mixed together and annealed to generate dsRNA by incubation at 65 uC for 20 min followed by a gradual and controlled cooling down to room temperature. After purification, dsRNAs were verified by agarose gel electrophoresis, quantified by using a UV spectrophotometer and stored at -80 uC for further in vivo experiments. The lengths of the synthesized CBP and EGFP dsRNAs in this study were 470 and 450 bp, respectively.
For dsRNA injection, 50 ml PBS containing CBP dsRNA was injected intramuscularly into Penaeus vannamei (~5 g body weight, each group had 20 shrimp) at a dose of 1 mg (g shrimp body weight) 21 . At the indicated times after injection, the pleopods were collected from shrimp in order to measure the results mentioned below. Experiments were repeated three times. Total RNAs were extracted with TRIzol reagent as mentioned earlier.
Expression and purification of recombinant WSSV envelope proteins (rVP24, rVP28, rVP31, rVP32, rVP39B, rVP53A and rVP56) and rCBP in Escherichia coli. The WSSV envelope proteins were amplified from the genomic DNA of WSSV Taiwan-1 with the following primer sets: VP24-F/VP24-R for VP24, VP28-F/ VP28-R for VP28, VP31-F/VP31-R for VP31, VP32-F/VP32-R for VP32, VP39B-F/VP39B-R for VP39B, VP53A-F/VP53A-R for VP53A, VP56-F/VP56-R for VP56 and CBP-F/CBP-R for CBP (Table S1 ). Recombinant MBP (rMBP) was set as negative control (Chen et al., 2009) . The underlined bases in Table S1 indicate the restriction sites for gene cloning. The recombinant plasmids were transformed into E. coli BL21(DE3) and cultures were induced with 1 mM IPTG and harvested. rCBP was also generated by the pET28b+ system. The resultant recombinant plasmid, pET28-PmCBP-C, was transformed into E. coli BL21(DE3). E. coli BL21(DE3) cells were cultured in LB medium with 25 mg kanamycin ml 21 and the protein was induced with 1 mM IPTG. The recombinant proteins tagged with His 6 were purified by QIAexpressionist Ni-NTA metal-affinity chromatography (Qiagen) according to the manufacturer's recommendations. The resins were washed with buffer (pH 8.0) containing 50 mM sodium phosphate, 0.3 M sodium chloride and 10 mM imidazole, and eluted with buffer (pH 8.0) containing 50 mM sodium phosphate, 0.3 M sodium chloride and 250 mM imidazole. The eluted proteins were all soluble. They were then concentrated using Amicon Ultra-15 centrifugal filters (Millipore) in PBS buffer, and stored at 4 uC for further antiserum production and far-Western blot assay. Generation of rCBP and polyclonal rabbit anti-CBP antibody was described in Chen et al. (2009) . Antisera production. Rabbits were used to develop polyclonal antiserum for each recombinant protein. In brief, New Zealand white rabbits were hyperimmunized by injection with 250 mg proteins emulsified in complete Freund's adjuvant. Subsequent booster injections were carried out with 250 mg protein emulsified in incomplete Freund's adjuvant. The antisera were collected after the antibody titre had peaked (Chen et al., 2007b) .
Western blot analysis. For Western blot analysis, 20 mg proteins that had been separated in SDS-PAGE were transferred onto a PVDF membrane (Micron Separations) by semi-dry blotting. Membranes were blocked in 5 % skim milk (Difco) in TBS (0.2 M NaCl, 50 mM Tris/HCl, pH 7.4). Immunodetection was performed by incubation of the blot in each polyclonal rabbit anti-recombinant protein serum diluted 1 : 5000 in TBS with 5 % skim milk for 1 h at room temperature. Subsequently, anti-rabbit IgG antibody conjugated with HRP (Sigma) was used at a concentration of 1 : 5000 and detection was performed with a Western blot chemiluminescence reagent (NEN Life Sciences).
Far-Western blot assay. Before the far-Western blot assay, all antisera were verified to recognize the specific protein on native WSSV without recognizing other proteins. The samples of 20 mg target viral envelope proteins were separated by SDS-PAGE, transferred to a PVDF membrane and renatured gradually at 4 uC overnight in HEPES buffer (20 mM HEPES, 100 mM NaCl, 1 mM EDTA, 1 mM DTT, 0.1 % Tween 20, 10 % glycerol, pH 7.5) containing 5 % non-fat milk. The blot was washed and incubated with 40 mg probe protein in 10 ml incubation buffer (20 mM Tris/HCl, 150 mM NaCl, 0.05 % Tween 20, 3 % non-fat milk, pH 7.5) for 2 h at room temperature. Then the blot was incubated in a polyclonal rabbit antibody against a probe protein of each binding protein diluted 1 : 5000 in TBST with 5 % skim milk for 1 h at room temperature. Subsequently, goat anti-rabbit IgG antibody conjugated with HRP (Jackson) was used at a concentration of 1 : 5000 and detection was performed with a Western Lightning Plus-ECL (Bioman).
His pull-down assay. The His pull-down assay was used to confirm the interaction between viral envelope proteins. The purified Histagged envelope proteins were bound to 20 ml Ni-NTA beads (Bioman) in PBS for 1 h with gentle rotation, mixing the sample with the beads, and then the beads were washed three times for 10 min each in PBS containing 0.1 % Triton X-100 and once in binding buffer (20 mM HEPES, 100 mM NaCl, 0.5 mM EDTA, 0.1 % Triton X-100, 10 % glycerol, pH 7.5). The beads were incubated in 200 ml binding buffer with purified WSSV virions and then washed 3 times with the binding buffer to remove non-specific binding. Bound proteins were eluted in 20 ml 26 SDS sample buffer and analysed by Western blot analysis (Liu et al., 2009) .
Membrane topology prediction and 3D models. The amino acid sequences for VP24, VP28, VP31, VP32, VP39B, VP53A and VP56 were downloaded from GenBank (http://ncbi.nlm.nih.gov). The web versions of three different topology prediction methods were used to model these eight envelope proteins: SOSUI (http://bp.nuap.nagoya-u. ac.jp/sosui/), TMHMM (http://www.cbs.dtu.dk/services/TMHMM-2.0/) and TMpred (http://www.ch.embnet.org/software/TMPRED_form.html). Graphics of the 3D model of the viral protein complex were produced with Google SketchUp 8.0.
